Stay updated with breaking news from Point Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
01.12.2021 - PRINCETON, N.J., Nov. 30, 2021 (GLOBE NEWSWIRE) - Oyster Point Pharma, Inc. (Nasdaq: OYST), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to ...
PRINCETON, N.J., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a commercial-stage biopharmaceutical company focused on the...
OYST earnings call for the period ending September 30, 2021.
TYRVAYA is the first and only nasal spray approved for the treatment of the signs and symptoms of dry eye disease TYRVAYA is designed to activate the...
ATR earnings call for the period ending September 30, 2021.